AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway

Roman Hrstka, Pavla Bouchalova, Eva Michalova, Eva Matoulkova, Petr Muller, Philip J. Coates, Borivoj Vojtesek
  • Molecular Oncology, December 2015, Wiley
  • DOI: 10.1016/j.molonc.2015.12.003
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Philip J Coates